CVS Health (NYSE:CVS) Earns Overweight Rating from Cantor Fitzgerald

Key Points

• CVS Health's stock has received an "overweight" rating from Cantor Fitzgerald, with a target price of $78.00, indicating a potential upside of 9.17% from its previous close.
• The company reported $1.81 EPS for its last quarter, exceeding analyst expectations of $1.46, with revenue reaching $98.92 billion, up 8.4% year-over-year.
• Investor interest is reflected in the stock's ratings, with 19 Buy ratings and only 1 Hold rating among analysts, and institutional investors owning 80.66% of the company’s shares.

CVS Health (NYSE:CVS - Get Free Report)'s stock had its "overweight" rating reissued by equities researchers at Cantor Fitzgerald in a report released on Tuesday,Benzinga reports. They presently have a $78.00 price target on the pharmacy operator's stock. Cantor Fitzgerald's price target points to a potential upside of 9.17% from the company's previous close.

Several other equities research analysts have also recently weighed in on CVS. Royal Bank Of Canada boosted their target price on CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research note on Monday, May 5th. Cowen restated a "buy" rating on shares of CVS Health in a research note on Monday, August 4th. Baird R W upgraded CVS Health from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 14th. Bernstein Bank decreased their target price on CVS Health from $78.00 to $72.00 and set a "market perform" rating for the company in a research note on Wednesday, July 16th. Finally, Morgan Stanley boosted their price objective on CVS Health from $80.00 to $82.00 and gave the company an "overweight" rating in a research note on Friday, August 1st. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $77.56.

CVS Health Stock Up 0.2%

Shares of CVS opened at $71.4490 on Tuesday. CVS Health has a 12-month low of $43.56 and a 12-month high of $72.51. The firm has a market cap of $90.62 billion, a P/E ratio of 19.98, a price-to-earnings-growth ratio of 0.79 and a beta of 0.58. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The company's 50-day moving average price is $65.57 and its 200 day moving average price is $65.37.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The business had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. During the same period in the previous year, the company posted $1.83 earnings per share. The business's revenue for the quarter was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, sell-side analysts forecast that CVS Health will post 5.89 earnings per share for the current year.

Insider Buying and Selling

In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of CVS Health stock in a transaction on Thursday, June 5th. The stock was bought at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the acquisition, the director owned 12,007 shares in the company, valued at $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.22% of the company's stock.

Institutional Investors Weigh In On CVS Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Avion Wealth grew its holdings in CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator's stock valued at $26,000 after purchasing an additional 189 shares during the last quarter. Harbor Asset Planning Inc. acquired a new stake in CVS Health in the second quarter valued at $30,000. Bell Investment Advisors Inc grew its holdings in CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator's stock valued at $31,000 after purchasing an additional 248 shares during the last quarter. Front Row Advisors LLC grew its holdings in CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator's stock valued at $31,000 after purchasing an additional 371 shares during the last quarter. Finally, McIlrath & Eck LLC grew its holdings in CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 174 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.